<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03950167</url>
  </required_header>
  <id_info>
    <org_study_id>20190328</org_study_id>
    <nct_id>NCT03950167</nct_id>
  </id_info>
  <brief_title>Gallbladder Functions &amp; Serum Cholecystokinin Levels in Women Diagnosed With Hyperemesis Gravidarum</brief_title>
  <official_title>Gallbladder Functions &amp; Serum Cholecystokinin Levels in Pregnant Women Diagnosed With Hyperemesis Gravidarum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M端ge Keskin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ufuk University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the gallbladder functions and serum cholecystokinin levels in pregnant
      women diagnosed with hyperemesis gravidarum. Half of the participants are healthy pregnant
      women and half of the participants are pregnant women diagnosed with hyperemesis gravidarum.
      Two groups will be compared by means of gallbladder functions and serum cholecystokinin
      levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previously gallbladder functions have been observed in human with gallbladder disease.
      However it has never been evaluated whether there is any difference in gallbladder functions
      between healthy pregnant women and pregnant women diagnosed with hyperemesis gravidarum.
      Moreover correlation between hyperemesis gravidarum symptom scores and gallbladder functions
      has never been assessed. There is also few data comparing serum cholecystokinin levels
      between healthy pregnant women and those diagnosed with hyperemesis gravidarum. The
      investigators will measure serum cholecystokinin levels after a fatty meal (100 g chocolate)
      and compare two groups. In this study the investigators would like to evaluate gallbladder
      functions and serum cholecystokinin levels in women with hyperemesis gravidarum and compare
      these with healthy subjects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gallbladder volume (gallbladder volume in ml)</measure>
    <time_frame>postprandial 30 minutes</time_frame>
    <description>Change from baseline gallbladder volume at postprandial 30 minutes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>gallbladder ejection fraction (gallbladder ejection fraction in percentage %)</measure>
    <time_frame>postprandial 30 minutes</time_frame>
    <description>gallbladder ejection fraction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum Cholecystokinin levels(Cholecystokinin levels in pg/ml)</measure>
    <time_frame>postprandial 10 minutes</time_frame>
    <description>Change from baseline Serum Cholecystokinin levels at postprandial 10 minutes</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hyperemesis Gravidarum</condition>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>Hyperemesis gravidarum</arm_group_label>
    <description>pregnant women before 14 weeks of pregnancy diagnosed with hyperemesis gravidarum will be assessed in terms of gallbladder functions and serum cholecystokinin levels after a fatty meal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy pregnant women</arm_group_label>
    <description>Healthy pregnant women before 14 weeks of pregnancy without hyperemesis gravidarum will be assessed in terms of gallbladder functions and serum cholecystokinin levels after a fatty meal.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        healthy pregnant women and pregnant women diagnosed with hyperemesis gravidarum before 14
        weeks of pregnancy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy pregnancies before 14 weeks of pregnancy without hyperemesis gravidarum

          -  pregnancies before 14 weeks of pregnancy diagnosed with hyperemesis gravidarum

        Exclusion Criteria:

          -  Multiple pregnancies

          -  Urinary tract infection

          -  peptic ulcer

          -  preexisting gallbladder disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muge Keskin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ufuk University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Muge Keskin</last_name>
    <phone>+905333522090</phone>
    <email>mugekeskin1@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ufuk University Hospital</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>m端ge keskin</last_name>
      <phone>+905333522090</phone>
      <email>mugekeskin1@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>m端ge keskin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 30, 2019</study_first_submitted>
  <study_first_submitted_qc>May 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2019</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ufuk University</investigator_affiliation>
    <investigator_full_name>M端ge Keskin</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>gallbladder functions</keyword>
  <keyword>cholecystokinin</keyword>
  <keyword>hyperemesis gravidarum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperemesis Gravidarum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

